Equity Overview
Price & Market Data
Price: $0.943
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $9,810,122
Daily Volume: 0
Performance Metrics
1 Week: 5.97%
1 Month: 4.26%
3 Months: 57.65%
6 Months: 56.39%
1 Year: 25.04%
YTD: 56.39%
Company Details
Employees: 23
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.